Atenolol 2 mg/mL oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Atenolol | active | 0.2 g |
| Citric acid monohydrate | buffer | 0.935 g |
| Sodium citrate dihydrate | buffer | 1.63 g |
| Sweeteners (see the study) | sweetener | See the study |
| SuspendIt | vehicle | q.s. to 100 mL |
- Strength
- 2 mg/mL
- Starting material
- Atenolol bulk powder
- Container
- See the study
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 180 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Room temperature | 180 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Mota S, Torres A, Quintas C, et al.. Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration. Pharmaceuticals (Basel). 2024;17(8):1052. PMID 39204157. PMC11359931. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.